The central vein sign and its clinical evaluation for the diagnosis of multiple sclerosis: A consensus statement from the North American Imaging in Multiple Sclerosis Cooperative

Pascal Sati; Jiwon Oh; R. Todd Constable; Nikos Evangelou; Charles R.G. Guttmann; Roland G. Henry; Eric C. Klawiter; Caterina Mainero; Luca Massacesi; Henry McFarland; Flavia Nelson; Daniel Ontaneda; Alexander Rauscher; William D. Rooney; Amal P.R. Samaraweera; Russell T. Shinohara; Raymond A. Sobel; Andrew J. Solomon; Constantina A. Treaba; Jens Wuerfel; Robert Zivadinov; Nancy L. Sicotte; Daniel Pelletier; Daniel S. Reich

doi:10.1038/nrneurol.2016.166

The central vein sign and its clinical evaluation for the diagnosis of multiple sclerosis: A consensus statement from the North American Imaging in Multiple Sclerosis Cooperative

Pascal Sati, Jiwon Oh, R. Todd Constable, Nikos Evangelou, Charles R.G. Guttmann, Roland G. Henry, Eric C. Klawiter, Caterina Mainero, Luca Massacesi, Henry McFarland, Flavia Nelson, Daniel Ontaneda, Alexander Rauscher, William D. Rooney, Amal P.R. Samaraweera, Russell T. Shinohara, Raymond A. Sobel, Andrew J. Solomon, Constantina A. Treaba, Jens WuerfelRobert Zivadinov, Nancy L. Sicotte, Daniel Pelletier, Daniel S. Reich

Neurology

Research output: Contribution to journal › Article › peer-review

126 Scopus citations

Abstract

Over the past few years, MRI has become an indispensable tool for diagnosing multiple sclerosis (MS). However, the current MRI criteria for MS diagnosis have imperfect sensitivity and specificity. The central vein sign (CVS) has recently been proposed as a novel MRI biomarker to improve the accuracy and speed of MS diagnosis. Evidence indicates that the presence of the CVS in individual lesions can accurately differentiate MS from other diseases that mimic this condition. However, the predictive value of the CVS for the development of clinical MS in patients with suspected demyelinating disease is still unknown. Moreover, the lack of standardization for the definition and imaging of the CVS currently limits its clinical implementation and validation. On the basis of a thorough review of the existing literature on the CVS and the consensus opinion of the members of the North American Imaging in Multiple Sclerosis (NAIMS) Cooperative, this article provides statements and recommendations aimed at helping radiologists and neurologists to better understand, refine, standardize and evaluate the CVS in the diagnosis of MS.

Original language	English (US)
Pages (from-to)	714-722
Number of pages	9
Journal	Nature Reviews Neurology
Volume	12
Issue number	12
DOIs	https://doi.org/10.1038/nrneurol.2016.166
State	Published - Dec 1 2016

Bibliographical note

Funding Information:
The authors would like to thank Christina J. Azevedo, Michael G. Dwyer, Léorah Freeman, Christoph Juchem, Shannon Kolind, Naila Makhani, Govind Nair, Nico Papinutto, Haochang Shou, Daniel Schwartz, Ferdinand Schweser, Elizabeth Sweeney, Ian Tagge, Shahamat Tauhid and Subhash Tummala for their participation in, and contribution to, the group workshop at the NAIMS meeting in Los Angeles. Matthew Schindler is acknowledged for helpful suggestions. The authors also acknowledge Rohit Bakshi, Peter Calabresi, Ciprian Crainiceanu and Jack Simon for their contribution as NAIMS members. The authors, on behalf of the NAIMS Cooperative, would also like to thank the Race to Erase Multiple Sclerosis for financial support, and Joel Arnold, Aracely Delgadillo, and Liz Seares for helping with organization of the NAIMS meeting. This research was supported in part by the Intramural Research Program of the National Institute of Neurological Disorders and Stroke.

Access

10.1038/nrneurol.2016.166

Fingerprint Dive into the research topics of 'The central vein sign and its clinical evaluation for the diagnosis of multiple sclerosis: A consensus statement from the North American Imaging in Multiple Sclerosis Cooperative'. Together they form a unique fingerprint.

Cite this

Sati, P., Oh, J., Todd Constable, R., Evangelou, N., Guttmann, C. R. G., Henry, R. G., Klawiter, E. C., Mainero, C., Massacesi, L., McFarland, H., Nelson, F., Ontaneda, D., Rauscher, A., Rooney, W. D., Samaraweera, A. P. R., Shinohara, R. T., Sobel, R. A., Solomon, A. J., Treaba, C. A., ... Reich, D. S. (2016). The central vein sign and its clinical evaluation for the diagnosis of multiple sclerosis: A consensus statement from the North American Imaging in Multiple Sclerosis Cooperative. Nature Reviews Neurology, 12(12), 714-722. https://doi.org/10.1038/nrneurol.2016.166

The central vein sign and its clinical evaluation for the diagnosis of multiple sclerosis : A consensus statement from the North American Imaging in Multiple Sclerosis Cooperative. / Sati, Pascal; Oh, Jiwon; Todd Constable, R.; Evangelou, Nikos; Guttmann, Charles R.G.; Henry, Roland G.; Klawiter, Eric C.; Mainero, Caterina; Massacesi, Luca; McFarland, Henry; Nelson, Flavia; Ontaneda, Daniel; Rauscher, Alexander; Rooney, William D.; Samaraweera, Amal P.R.; Shinohara, Russell T.; Sobel, Raymond A.; Solomon, Andrew J.; Treaba, Constantina A.; Wuerfel, Jens; Zivadinov, Robert; Sicotte, Nancy L.; Pelletier, Daniel; Reich, Daniel S.

In: Nature Reviews Neurology, Vol. 12, No. 12, 01.12.2016, p. 714-722.

Research output: Contribution to journal › Article › peer-review

Sati, P, Oh, J, Todd Constable, R, Evangelou, N, Guttmann, CRG, Henry, RG, Klawiter, EC, Mainero, C, Massacesi, L, McFarland, H, Nelson, F, Ontaneda, D, Rauscher, A, Rooney, WD, Samaraweera, APR, Shinohara, RT, Sobel, RA, Solomon, AJ, Treaba, CA, Wuerfel, J, Zivadinov, R, Sicotte, NL, Pelletier, D & Reich, DS 2016, 'The central vein sign and its clinical evaluation for the diagnosis of multiple sclerosis: A consensus statement from the North American Imaging in Multiple Sclerosis Cooperative', Nature Reviews Neurology, vol. 12, no. 12, pp. 714-722. https://doi.org/10.1038/nrneurol.2016.166

Sati, Pascal ; Oh, Jiwon ; Todd Constable, R. ; Evangelou, Nikos ; Guttmann, Charles R.G. ; Henry, Roland G. ; Klawiter, Eric C. ; Mainero, Caterina ; Massacesi, Luca ; McFarland, Henry ; Nelson, Flavia ; Ontaneda, Daniel ; Rauscher, Alexander ; Rooney, William D. ; Samaraweera, Amal P.R. ; Shinohara, Russell T. ; Sobel, Raymond A. ; Solomon, Andrew J. ; Treaba, Constantina A. ; Wuerfel, Jens ; Zivadinov, Robert ; Sicotte, Nancy L. ; Pelletier, Daniel ; Reich, Daniel S. / The central vein sign and its clinical evaluation for the diagnosis of multiple sclerosis : A consensus statement from the North American Imaging in Multiple Sclerosis Cooperative. In: Nature Reviews Neurology. 2016 ; Vol. 12, No. 12. pp. 714-722.

@article{5b64c35c5e5e48d3a85a00064b06c1b7,

title = "The central vein sign and its clinical evaluation for the diagnosis of multiple sclerosis: A consensus statement from the North American Imaging in Multiple Sclerosis Cooperative",

abstract = "Over the past few years, MRI has become an indispensable tool for diagnosing multiple sclerosis (MS). However, the current MRI criteria for MS diagnosis have imperfect sensitivity and specificity. The central vein sign (CVS) has recently been proposed as a novel MRI biomarker to improve the accuracy and speed of MS diagnosis. Evidence indicates that the presence of the CVS in individual lesions can accurately differentiate MS from other diseases that mimic this condition. However, the predictive value of the CVS for the development of clinical MS in patients with suspected demyelinating disease is still unknown. Moreover, the lack of standardization for the definition and imaging of the CVS currently limits its clinical implementation and validation. On the basis of a thorough review of the existing literature on the CVS and the consensus opinion of the members of the North American Imaging in Multiple Sclerosis (NAIMS) Cooperative, this article provides statements and recommendations aimed at helping radiologists and neurologists to better understand, refine, standardize and evaluate the CVS in the diagnosis of MS.",

author = "Pascal Sati and Jiwon Oh and {Todd Constable}, R. and Nikos Evangelou and Guttmann, {Charles R.G.} and Henry, {Roland G.} and Klawiter, {Eric C.} and Caterina Mainero and Luca Massacesi and Henry McFarland and Flavia Nelson and Daniel Ontaneda and Alexander Rauscher and Rooney, {William D.} and Samaraweera, {Amal P.R.} and Shinohara, {Russell T.} and Sobel, {Raymond A.} and Solomon, {Andrew J.} and Treaba, {Constantina A.} and Jens Wuerfel and Robert Zivadinov and Sicotte, {Nancy L.} and Daniel Pelletier and Reich, {Daniel S.}",

note = "Funding Information: The authors would like to thank Christina J. Azevedo, Michael G. Dwyer, L{\'e}orah Freeman, Christoph Juchem, Shannon Kolind, Naila Makhani, Govind Nair, Nico Papinutto, Haochang Shou, Daniel Schwartz, Ferdinand Schweser, Elizabeth Sweeney, Ian Tagge, Shahamat Tauhid and Subhash Tummala for their participation in, and contribution to, the group workshop at the NAIMS meeting in Los Angeles. Matthew Schindler is acknowledged for helpful suggestions. The authors also acknowledge Rohit Bakshi, Peter Calabresi, Ciprian Crainiceanu and Jack Simon for their contribution as NAIMS members. The authors, on behalf of the NAIMS Cooperative, would also like to thank the Race to Erase Multiple Sclerosis for financial support, and Joel Arnold, Aracely Delgadillo, and Liz Seares for helping with organization of the NAIMS meeting. This research was supported in part by the Intramural Research Program of the National Institute of Neurological Disorders and Stroke.",

year = "2016",

month = dec,

day = "1",

doi = "10.1038/nrneurol.2016.166",

language = "English (US)",

volume = "12",

pages = "714--722",

journal = "Nature Reviews Neurology",

issn = "1759-4758",

publisher = "Nature Publishing Group",

number = "12",

}

TY - JOUR

T1 - The central vein sign and its clinical evaluation for the diagnosis of multiple sclerosis

T2 - A consensus statement from the North American Imaging in Multiple Sclerosis Cooperative

AU - Sati, Pascal

AU - Oh, Jiwon

AU - Todd Constable, R.

AU - Evangelou, Nikos

AU - Guttmann, Charles R.G.

AU - Henry, Roland G.

AU - Klawiter, Eric C.

AU - Mainero, Caterina

AU - Massacesi, Luca

AU - McFarland, Henry

AU - Nelson, Flavia

AU - Ontaneda, Daniel

AU - Rauscher, Alexander

AU - Rooney, William D.

AU - Samaraweera, Amal P.R.

AU - Shinohara, Russell T.

AU - Sobel, Raymond A.

AU - Solomon, Andrew J.

AU - Treaba, Constantina A.

AU - Wuerfel, Jens

AU - Zivadinov, Robert

AU - Sicotte, Nancy L.

AU - Pelletier, Daniel

AU - Reich, Daniel S.

N1 - Funding Information: The authors would like to thank Christina J. Azevedo, Michael G. Dwyer, Léorah Freeman, Christoph Juchem, Shannon Kolind, Naila Makhani, Govind Nair, Nico Papinutto, Haochang Shou, Daniel Schwartz, Ferdinand Schweser, Elizabeth Sweeney, Ian Tagge, Shahamat Tauhid and Subhash Tummala for their participation in, and contribution to, the group workshop at the NAIMS meeting in Los Angeles. Matthew Schindler is acknowledged for helpful suggestions. The authors also acknowledge Rohit Bakshi, Peter Calabresi, Ciprian Crainiceanu and Jack Simon for their contribution as NAIMS members. The authors, on behalf of the NAIMS Cooperative, would also like to thank the Race to Erase Multiple Sclerosis for financial support, and Joel Arnold, Aracely Delgadillo, and Liz Seares for helping with organization of the NAIMS meeting. This research was supported in part by the Intramural Research Program of the National Institute of Neurological Disorders and Stroke.

PY - 2016/12/1

Y1 - 2016/12/1

N2 - Over the past few years, MRI has become an indispensable tool for diagnosing multiple sclerosis (MS). However, the current MRI criteria for MS diagnosis have imperfect sensitivity and specificity. The central vein sign (CVS) has recently been proposed as a novel MRI biomarker to improve the accuracy and speed of MS diagnosis. Evidence indicates that the presence of the CVS in individual lesions can accurately differentiate MS from other diseases that mimic this condition. However, the predictive value of the CVS for the development of clinical MS in patients with suspected demyelinating disease is still unknown. Moreover, the lack of standardization for the definition and imaging of the CVS currently limits its clinical implementation and validation. On the basis of a thorough review of the existing literature on the CVS and the consensus opinion of the members of the North American Imaging in Multiple Sclerosis (NAIMS) Cooperative, this article provides statements and recommendations aimed at helping radiologists and neurologists to better understand, refine, standardize and evaluate the CVS in the diagnosis of MS.

AB - Over the past few years, MRI has become an indispensable tool for diagnosing multiple sclerosis (MS). However, the current MRI criteria for MS diagnosis have imperfect sensitivity and specificity. The central vein sign (CVS) has recently been proposed as a novel MRI biomarker to improve the accuracy and speed of MS diagnosis. Evidence indicates that the presence of the CVS in individual lesions can accurately differentiate MS from other diseases that mimic this condition. However, the predictive value of the CVS for the development of clinical MS in patients with suspected demyelinating disease is still unknown. Moreover, the lack of standardization for the definition and imaging of the CVS currently limits its clinical implementation and validation. On the basis of a thorough review of the existing literature on the CVS and the consensus opinion of the members of the North American Imaging in Multiple Sclerosis (NAIMS) Cooperative, this article provides statements and recommendations aimed at helping radiologists and neurologists to better understand, refine, standardize and evaluate the CVS in the diagnosis of MS.

UR - http://www.scopus.com/inward/record.url?scp=84994718072&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84994718072&partnerID=8YFLogxK

U2 - 10.1038/nrneurol.2016.166

DO - 10.1038/nrneurol.2016.166

M3 - Article

C2 - 27834394

AN - SCOPUS:84994718072

VL - 12

SP - 714

EP - 722

JO - Nature Reviews Neurology

JF - Nature Reviews Neurology

SN - 1759-4758

IS - 12

ER -